Top

Published in:

01-11-2020 | Magnetic Resonance Imaging | Special Section: Chronic Liver Disease

Hepatic nodules with arterial phase hyperenhancement and washout on enhanced computed tomography/magnetic resonance imaging: how to avoid pitfalls

Authors: Mimi Tang, Yin Li, Zhi Lin, Bingqi Shen, Mengqi Huang, Zi-Ping Li, Xuehua Li, Shi-Ting Feng

Published in: Abdominal Radiology | Issue 11/2020

Abstract

This essay aimed to illustrate the various hepatic nodules that may exhibit arterial phase hyperenhancement and washout on computed tomography/magnetic resonance imaging (CT/MRI). Hepatic nodules with arterial phase hyperenhancement and washout on CT/MRI include hepatocellular carcinoma, focal nodular hyperplasia-like nodules, serum amyloid A-positive hepatocellular neoplasms, intrahepatic cholangiocarcinoma, intrahepatic bile duct adenoma, hepatoblastoma, hepatocellular adenoma, hepatic epithelioid angiomyolipoma, and metastasis including neuroendocrine and gastrointestinal stromal tumors. Understanding the imaging findings is important to ensure correct diagnosis.

Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, Roberts LR, Heimbach JK (2018) Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 68 (2):723-750. https://doi.org/10.1002/hep.29913CrossRefPubMed

Kim MJ, Lee S, An C (2019) Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma. Eur Radiol 29 (9):5101-5110. https://doi.org/10.1007/s00330-019-06030-0CrossRefPubMed

Victoria C, Claude BS (2018) The LI-RADS v2018 Manual. ACR. https://www.acr.org/-/media/ACR/Files/Clinical-Resources/LIRADS/LI-RADS-2018-Manual-5Dec18.pdf

[4] Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. The Lancet 391 (10127):1301-1314. https://doi.org/10.1016/s0140-6736(18)30010-2CrossRef

Kitao A, Zen Y, Matsui O, Gabata T, Nakanuma Y (2009) Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography--radiologic-pathologic correlation. Radiology 252 (2):605-614. https://doi.org/10.1148/radiol.2522081414CrossRefPubMed

European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L (2018) EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. Journal of hepatology 69 (1):182-236. https://doi.org/10.1016/j.jhep.2018.03.019CrossRef

Gupta S, Bent S, Kohlwes J (2003) Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann Intern Med 139 (1):46–50. https://doi.org/10.7326/0003-4819-139-1-200307010-00012

Li XW, Cai HS, Yang YH, Li C, Dong Z, Feng S-T, Luo YJ (2017) Application of enhanced MR multi-phase dynamic scanning with 3D-VIBE sequence in hepatocellular carcinoma. Journal of Sun Yat-sen University (Medical Sciences) 38 (6):900-908. https://doi.org/10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2017.0143CrossRef

Iannaccone R, Piacentini F, Murakami T, Paradis V, Belghiti J, Hori M, Kim T, Durand F, Wakasa K, Monden M, Nakamura H, Passariello R, Vilgrain V (2007) Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison. Radiology 243 (2):422-430. https://doi.org/10.1148/radiol.2432051244CrossRefPubMed

10.

Papadatos D, Fowler KJ, Kielar AZ, Cui J, Sirlin CB (2017) Cirrhosis and LI-RADS. Abdominal Radiology 43 (1):26-40. https://doi.org/10.1007/s00261-017-1425-8CrossRef

11.

Quaglia A, Tibballs J, Grasso A, Prasad N, Nozza P, Davies SE, Burroughs AK, Watkinson A, Dhillon AP (2003) Focal nodular hyperplasia-like areas in cirrhosis. Histopathology 42 (1):14-21. https://doi.org/10.1046/j.1365-2559.2003.01550.xCrossRefPubMed

12.

Nakashima O, Kurogi M, Yamaguchi R, Miyaaki H, Fujimoto M, Yano H, Kumabe T, Hayabuchi N, Hisatomi J, Sata M, Kojiro M (2004) Unique hypervascular nodules in alcoholic liver cirrhosis: identical to focal nodular hyperplasia-like nodules? Journal of Hepatology 41 (6):992-998. https://doi.org/10.1016/j.jhep.2004.08.014CrossRefPubMed

13.

Libbrecht L, Cassiman D, Verslype C, Maleux G, Van Hees D, Pirenne J, Nevens F, Roskams T (2006) Clinicopathological features of focal nodular hyperplasia-like nodules in 130 cirrhotic explant livers. Am J Gastroenterol 101 (10):2341-2346. https://doi.org/10.1111/j.1572-0241.2006.00783.xCrossRefPubMed

14.

Kim SR, Imoto S, Ikawa H, Ando K, Mita K, Shimizu K, Taniguchi M, Sasase N, Matsuoka T, Kudo M, Kawada N, Hayashi Y (2008) Focal nodular hyperplasia-like lesion with venous washout in alcoholic liver cirrhosis. Intern Med 47 (21):1899-1903. https://doi.org/10.2169/internalmedicine.47.1221CrossRefPubMed

15.

Yoneda N, Matsui O, Kitao A, Kozaka K, Kobayashi S, Sasaki M, Yoshida K, Inoue D, Minami T, Gabata T (2016) Benign Hepatocellular Nodules: Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging Based on Molecular Background. Radiographics : a review publication of the Radiological Society of North America, Inc 36 (7):2010–2027. https://doi.org/10.1148/rg.2016160037

16.

Kim JW, Lee CH, Kim SB, Park BN, Park YS, Lee J, Park CM (2017) Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: A differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules. J Magn Reson Imaging 45 (6):1599-1608. https://doi.org/10.1002/jmri.25493CrossRefPubMed

17.

Calderaro J, Nault JC, Balabaud C, Couchy G, Saint-Paul M-C, Azoulay D, Mehdaoui D, Luciani A, Zafrani ES, Bioulac-Sage P, Zucman-Rossi J (2015) Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis. Modern Pathology 29 (1):43-50. https://doi.org/10.1038/modpathol.2015.119CrossRefPubMed

18.

Sasaki M, Yoneda N, Sawai Y, Imai Y, Kondo F, Fukusato T, Yoshikawa S, Kobayashi S, Sato Y, Matsui O, Nakanuma Y (2015) Clinicopathological characteristics of serum amyloid A-positive hepatocellular neoplasms/nodules arising in alcoholic cirrhosis. Histopathology 66 (6):836-845. https://doi.org/10.1111/his.12588CrossRefPubMed

19.

Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA (2005) Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 128 (3):620-626. https://doi.org/10.1053/j.gastro.2004.12.048CrossRefPubMed

20.

Razumilava N, Gores GJ (2014) Cholangiocarcinoma. The Lancet 383 (9935):2168-2179. https://doi.org/10.1016/s0140-6736(13)61903-0CrossRef

21.

Huang B, Wu L, Lu X-Y, Xu F, Liu C-F, Shen W-F, Jia N-Y, Cheng H-Y, Yang Y-F, Shen F (2016) Small Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in Cirrhotic Livers May Share Similar Enhancement Patterns at Multiphase Dynamic MR Imaging. Radiology 281 (1):150-157. https://doi.org/10.1148/radiol.2016151205CrossRefPubMed

22.

Ni T, Shang X-S, Wang W-T, Hu X-X, Zeng M-S, Rao S-X (2018) Different MR features for differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma according to tumor size. The British journal of radiology 91 (1088):20180017-20180017. https://doi.org/10.1259/bjr.20180017CrossRefPubMedPubMedCentral

23.

An C, Park S, Choi YJ (2013) Diffusion-weighted MRI in intrahepatic bile duct adenoma arising from the cirrhotic liver. Korean J Radiol 14 (5):769-775. https://doi.org/10.3348/kjr.2013.14.5.769CrossRefPubMedPubMedCentral

24.

Allaire GS, Rabin L, Ishak KG, Sesterhenn IA (1988) Bile duct adenoma. A study of 152 cases. The American journal of surgical pathology 12 (9):708–715. https://doi.org/10.1097/00000478-198809000-00007

25.

Fred TB, Fatima C, Ralph HH, Neil DT (2010) WHO classification of tumours of the digestive system. International Agency for Research on Cancer, Lyon

26.

Kim YS, Rha SE, Oh SN, Jung SE, Shin YR, Choi BG, Byun JY, Jung ES, Kim DG (2010) Imaging findings of intrahepatic bile duct adenoma (peribiliary gland hamartoma): a case report and literature review. Korean J Radiol 11 (5):560-565. https://doi.org/10.3348/kjr.2010.11.5.560CrossRefPubMedPubMedCentral

27.

Meyers AB, Towbin AJ, Geller JI, Podberesky DJ (2012) Hepatoblastoma imaging with gadoxetate disodium-enhanced MRI--typical, atypical, pre- and post-treatment evaluation. Pediatr Radiol 42 (7):859-866. https://doi.org/10.1007/s00247-012-2366-6CrossRefPubMed

28.

Rodriguez-Galindo C, Krailo M, Frazier L, Chintagumpala M, Amatruda J, Katzenstein H, Malogolowkin M, Spector L, Pashankar F, Meyers R, Tomlinson G, Committee COGRTD (2013) Children's Oncology Group's 2013 blueprint for research: rare tumors. Pediatr Blood Cancer 60 (6):1016-1021. https://doi.org/10.1002/pbc.24428CrossRefPubMed

29.

Kremer N, Walther AE, Tiao GM (2014) Management of hepatoblastoma: an update. Current opinion in pediatrics 26 (3):362-369. https://doi.org/10.1097/MOP.0000000000000081CrossRefPubMed

30.

Meyers RL (2007) Tumors of the liver in children. Surg Oncol 16 (3):195-203. https://doi.org/10.1016/j.suronc.2007.07.002CrossRefPubMed

31.

Wang TY, Han YL, Gao YJ, Xu M, Gu S, Yin MZ, Zhong YM, Hu WT, Pan C, Tang JY (2019) Retrospective Analysis of Childhood Hepatoblastoma in a Single Centre in China. Clinical Oncology 31 (7):471-478. https://doi.org/10.1016/j.clon.2019.03.044CrossRefPubMed

32.

Chung EM, Lattin GE, Jr., Cube R, Lewis RB, Marichal-Hernández C, Shawhan R, Conran RM (2011) From the archives of the AFIP: Pediatric liver masses: radiologic-pathologic correlation. Part 2. Malignant tumors. Radiographics : a review publication of the Radiological Society of North America, Inc 31 (2):483–507. https://doi.org/10.1148/rg.312105201

33.

Lin H, van den Esschert J, Liu C, van Gulik TM (2011) Systematic review of hepatocellular adenoma in China and other regions. Journal of Gastroenterology and Hepatology 26 (1):28-35. https://doi.org/10.1111/j.1440-1746.2010.06502.xCrossRefPubMed

34.

Nault JC, Paradis V, Cherqui D, Vilgrain V, Zucman-Rossi J (2017) Molecular classification of hepatocellular adenoma in clinical practice. J Hepatol 67 (5):1074-1083. https://doi.org/10.1016/j.jhep.2017.07.009CrossRefPubMed

35.

Ba-Ssalamah A, Antunes C, Feier D, Bastati N, Hodge JC, Stift J, Cipriano MA, Wrba F, Trauner M, Herold CJ, Caseiro-Alves F (2015) Morphologic and Molecular Features of Hepatocellular Adenoma with Gadoxetic Acid-enhanced MR Imaging. Radiology 277 (1):104-113. https://doi.org/10.1148/radiol.2015142366CrossRefPubMed

36.

Bioulac-Sage P, Sempoux C, Frulio N, Le Bail B, Blanc JF, Castain C, Laurent C, Trillaud H, Chiche L, Balabaud C (2019) Snapshot summary of diagnosis and management of hepatocellular adenoma subtypes. Clinics and Research in Hepatology and Gastroenterology 43 (1):12-19. https://doi.org/10.1016/j.clinre.2018.07.007CrossRefPubMed

37.

van Aalten SM, Thomeer MGJ, Terkivatan T, Dwarkasing RS, Verheij J, de Man RA, Ijzermans JNM (2011) Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology 261 (1):172-181. https://doi.org/10.1148/radiol.11110023CrossRefPubMed

38.

Mao JX, Teng F, Liu C, Yuan H, Sun KY, Zou Y, Dong JY, Ji JS, Dong JF, Fu H, Ding GS, Guo WY (2019) Two case reports and literature review for hepatic epithelioid angiomyolipoma: Pitfall of misdiagnosis. World J Clin Cases 7 (8):972-983. https://doi.org/10.12998/wjcc.v7.i8.972CrossRefPubMedPubMedCentral

39.

Klompenhouwer AJ, Verver D, Janki S, Bramer WM, Doukas M, Dwarkasing RS, de Man RA, Ijzermans JNM (2017) Management of hepatic angiomyolipoma: A systematic review. Liver International 37 (9):1272-1280. https://doi.org/10.1111/liv.13381CrossRefPubMed

40.

Chia HW, Nai CC, Yi CY, Yu K, Sz SY, Ching YW, Chien AL, Yi HC, Yi YC (2016) Uncommon liver tumors: Case report and literature review. Medicine 95 (39):e4952. https://doi.org/10.1097/md.0000000000004952CrossRef

41.

Danet I-M, Semelka RC, Leonardou P, Braga L, Vaidean G, Woosley JT, Kanematsu M (2003) Spectrum of MRI appearances of untreated metastases of the liver. AJR American journal of roentgenology 181 (3):809-817. https://doi.org/10.2214/ajr.181.3.1810809CrossRefPubMed

42.

Gulpinar B, Peker E, Kul M, Elhan AH, Haliloglu N (2019) Liver metastases of neuroendocrine tumors: is it possible to diagnose different histologic subtypes depending on multiphasic CT features? Abdominal Radiology 44 (6):2147-2155. https://doi.org/10.1007/s00261-019-01963-yCrossRefPubMed

43.

Park YS (2016) Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents? World Journal of Gastroenterology 22 (1). https://doi.org/10.3748/wjg.v22.i1.284

44.

Ronot M, Cuccioli F, Dioguardi Burgio M, Vullierme M-P, Hentic O, Ruszniewski P, d’Assignies G, Vilgrain V (2017) Neuroendocrine liver metastases: Vascular patterns on triple-phase MDCT are indicative of primary tumour location. European Journal of Radiology 89:156-162. https://doi.org/10.1016/j.ejrad.2017.02.007CrossRefPubMed

45.

Sandrasegaran K, Rajesh A, Rushing DA, Rydberg J, Akisik FM, Henley JD (2005) Gastrointestinal stromal tumors: CT and MRI findings. Eur Radiol 15 (7):1407-1414. https://doi.org/10.1007/s00330-005-2647-7CrossRefPubMed

46.

Gaitanidis A, Alevizakos M, Tsaroucha A, Simopoulos C, Pitiakoudis M (2018) Incidence and predictors of synchronous liver metastases in patients with gastrointestinal stromal tumors (GISTs). Am J Surg 216 (3):492-497. https://doi.org/10.1016/j.amjsurg.2018.04.011CrossRefPubMed

Title: Hepatic nodules with arterial phase hyperenhancement and washout on enhanced computed tomography/magnetic resonance imaging: how to avoid pitfalls
Authors: Mimi Tang
Yin Li
Zhi Lin
Bingqi Shen
Mengqi Huang
Zi-Ping Li
Xuehua Li
Shi-Ting Feng
Publication date: 01-11-2020
Publisher: Springer US
Keywords: Magnetic Resonance Imaging
Magnetic Resonance Imaging
Computed Tomography
Metastasis
Computed Tomography
Hepatic Adenoma
Hepatocellular Carcinoma
Hepatocellular Carcinoma
Gastrointestinal Stromal Tumor
Focal Nodular Hyperplasia
Published in: Abdominal Radiology / Issue 11/2020
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-020-02560-0

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Hepatic nodules with arterial phase hyperenhancement and washout on enhanced computed tomography/magnetic resonance imaging: how to avoid pitfalls

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2020

Natural history of hepatocellular carcinoma after stereotactic body radiation therapy

CT texture analysis for the differentiation of papillary renal cell carcinoma subtypes

CT-guided cryoablation of renal cancer: radiation burden and the associated risk of secondary cancer from procedural- and follow-up imaging

Commentary: Ureteral pseudodiverticulosis is diagnosable on computed tomography

Multiparametric MR mapping in clinical decision-making for diffuse liver disease

MR imaging assessment and quantification of liver iron

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page